Press releases

Release issued 4th January 2008

TAMPA, Florida & YORK, England

UTEK Corporation (LSE-AIM & AMEX:UTK), an open innovation company focused on technology transfer, has completed acquisition of Pharmalicensing, Ltd. through its subsidiary UTEK Europe, Ltd. Pharmalicensing is a leading open innovation service for partnering, licensing and business development within the international life science and biopharmaceutical industry.

Based in York, England, Pharmalicensing makes it easy for over 200 active clients to post descriptions of technologies that they are seeking to either in-license or out-license and to augment their internal R&D and business development programs. The acquisition of Pharmalicensing represents an extension of UTEK’s open innovation services and increases its presence within the life sciences sector.

“We believe that the acquisition of Pharmalicensing fits our strategy of becoming the leading provider of Open Innovation services and expands our existing operations within the UK market. We look forward to the opportunity to integrate and grow the business with UTEK’s unique technology transfer capabilities,” said Clifford M. Gross, Ph.D., UTEK’s Chief Executive Officer.

About UTEK Corporation

UTEK® is an open innovation company focused on technology transfer. UTEK’s services enable companies to acquire externally developed technologies from academic, federal and research laboratories worldwide. In addition, UTEK provides services to help companies create value from their intellectual property. UTEK is a business development company with operations in the United States, United Kingdom and Israel. For more information about UTEK, please visit its website at www.utekcorp.com.

About Pharmalicensing, Ltd.

Pharmalicensing is a leading open innovation resource for partnering, licensing and business development within the international life science and biopharmaceutical industry. Pharmalicensing services complement and enhance business development throughout the deal making process, from finding partners to closing the transaction. For more information about Pharmalicensing, please visit its website at www.pharmalicensing.com.

(20th May 2013) Pharmalicensing and Bionow sign strategic marketing and member benefit agreement

(5th January 2012) Innovaro Announces Successful Sale of the Waycool Portfolio of Patents by CUI Global, Inc.

(28th January 2010) New collaboration presents big opportunities for UK SMEs

(14th January 2010) UTEK Pharmalicensing.com Announces New Pricing Model: Pay-per-Click to Expand Listed Opportunities, Extend Reach and Remove Market Barriers

(25th July 2007) Pharmalicensing launches 3rd edition of top selling licensing agreement report